For patients with cancer, prior authorization requirements and coverage stoppages generate barriers to life saving therapies and care, according to a first-of-its-kind national survey entitled “The Health Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management” from CancerCare.

Dermatologists had hoped that an active sunscreen ingredient popular in Europe would be available in the U.S. by summer — but the Food and Drug Administration still hasn't approved it.

Even before he trained as an otolaryngologist, researcher Anthony Law understood that all of us are natural voice scientists with the intuitive power to hear peoples’ voices and know something’s wrong.

AI could help radiologists identify a significant number of interval breast cancer cases earlier in the screening process, according to results of a retrospective study.

Cynthia Cherish Malaran didn't like the piano lessons she took as a child, so it amused the native New Yorker that she found second-career success as a DJ a decade ago, spinning tunes for MTV, Lincoln Center and other clients.

To Rebecca Stone, the single most important fact about ovarian cancer is that it’s usually a misnomer.

Dr. Allison Rosenthal's experience facing a leukemia diagnosis while in medical school inspired her to pursue a career fighting cancer.

“It’s nothing,” Tom, a retired firefighter from rural Texas, thought when he had persistent stomach pain.

A new study from the National Institutes of Health (NIH) has found that the incidence of 14 different cancer types increased among people under the age of 50.

Findings from a first-of-its-kind national survey are included in “The Health Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management,” a new report from CancerCare which details the impact that prior authorization requirement and coverage stoppages have on patients with cancer.